OPRX
OptimizeRx Corp
Recent 8-K filings for OPRX
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 12, 2026 20:07 UTC earnings item 1.01item 1.02item 2.02item 2.03item 9.01
OptimizeRx Q1 rev $19.8M, adj EBITDA $3.3M; guides FY rev $95-100M, refi saves $1.5M
source · OPRX on sec.gov